Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogen (NEOG) Gains from Sales and Divestitures (2022 - 2025)

Neogen has reported Gains from Sales and Divestitures over the past 4 years, most recently at $374000.0 for Q2 2025.

  • Quarterly results put Gains from Sales and Divestitures at $374000.0 for Q2 2025, up 62.61% from a year ago — trailing twelve months through May 2025 was $374000.0 (up 62.61% YoY), and the annual figure for FY2025 was $374000.0, up 62.61%.
  • Gains from Sales and Divestitures for Q2 2025 was $374000.0 at Neogen, up from $230000.0 in the prior quarter.
  • Over the last five years, Gains from Sales and Divestitures for NEOG hit a ceiling of $374000.0 in Q2 2025 and a floor of $25000.0 in Q2 2022.
  • Median Gains from Sales and Divestitures over the past 4 years was $145000.0 (2023), compared with a mean of $172250.0.
  • Biggest five-year swings in Gains from Sales and Divestitures: surged 283.33% in 2024 and later skyrocketed 62.61% in 2025.
  • Neogen's Gains from Sales and Divestitures stood at $25000.0 in 2022, then soared by 140.0% to $60000.0 in 2023, then surged by 283.33% to $230000.0 in 2024, then surged by 62.61% to $374000.0 in 2025.
  • The last three reported values for Gains from Sales and Divestitures were $374000.0 (Q2 2025), $230000.0 (Q2 2024), and $60000.0 (Q2 2023) per Business Quant data.